文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新型冠状病毒肺炎合并气胸7例临床特征分析

[Clinical characteristics of coronavirus disease 2019 patients complicated with pneumothorax: analysis of 7 cases].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论COVID-19合并气胸预后差,气管插管后发生气胸的6例中4例死亡,需高度重视并早期识别。

该研究回顾性分析2020年1月3日至3月10日黄冈市中心医院收治的7例COVID-19合并气胸患者的临床资料。7例中6例为右侧气胸、1例双侧气胸,住院时间均超过4周,多合并多器官功能障碍。6例危重型患者接受气管插管机械通气,其中5例在气胸发生后3天内行机械通气;气管插管后合并气胸的6例中4例死亡,另2例胸腔闭式引流2周内成功拔管。结论认为COVID-19合并气胸病情凶险、预后差,应充分重视。

要点

  • COVID-19合并气胸患者住院时间均超过4周,多合并多器官功能障碍,病情凶险。
  • 7例中6例为右侧气胸、1例为双侧气胸,影像多见双肺弥漫实变、条索影及纤维化、胸膜粘连明显。
  • 6例危重型患者接受气管插管机械通气,5例在气胸发生后3天内行机械通气,1例在11天后。
  • 气管插管后合并气胸的6例中4例死亡,另2例胸腔闭式引流2周内成功拔管、病情逐渐稳定。
  • 1例未行气管插管的患者持续经鼻高流量氧疗,病情稳定。

适用人群与场景

  • 2020年1月3日至3月10日黄冈市中心医院收治的COVID-19合并气胸患者7例,其中男5例、女2例。
  • 7例中4例无基础疾病,1例有糖尿病和高血压病史,1例仅有高血压病史。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 1例发病4周后出现气胸的重症患者给予无创机械通气。
  • 其余6例危重型患者接受气管插管和机械通气。
  • 6例气管插管后合并气胸的患者中,5例在气胸发生后3天内行机械通气,1例在11天后行机械通气。
  • 2例患者经胸腔闭式引流,2周内成功拔除引流管,病情逐渐稳定。
  • 1例未行气管插管的患者持续给予经鼻高流量氧疗,病情稳定。

红旗征与不能漏的情况

  • COVID-19合并气胸是危险疾病、预后差,应予以充分重视。
  • 气管插管后发生气胸的6例中4例死亡,提示气管插管后气胸提示极高死亡风险。
  • 影像见双肺弥漫实变、条索影及纤维化、胸膜粘连明显者,病变吸收极慢,需警惕气胸发生。

研究设计与关键结果

  • 研究类型为回顾性分析,样本量7例,单中心(黄冈市中心医院),人群为COVID-19合并气胸患者。
  • 7例中6例右侧气胸、1例双侧气胸,住院时间均超过4周,多合并多器官功能障碍。
  • 1例1周内由早期进展至进展期、2周内进展至危重型,4周后发生气胸,2周内吸收。
  • 其余6例入院时即为进展期,均在1~2周内进展至危重型,多表现为双肺弥漫实变影、条索影及纤维化,胸膜粘连明显,病灶吸收极慢。
  • 气管插管后合并气胸的6例中4例死亡,2例胸腔闭式引流2周内成功拔管、病情逐渐稳定。

证据类型、等级与局限

  • 证据类型为回顾性病例分析,单中心,样本量仅7例,无对照组,原文未给出证据等级或推荐强度。
  • 局限:回顾性设计、样本量小、单中心,结论外推需谨慎。

对床旁实践的改变

  • 对COVID-19患者应警惕气胸并发症,尤其是气管插管机械通气后者,本组气管插管后合并气胸6例中4例死亡。
  • COVID-19合并气胸患者影像常见双肺弥漫实变、条索影及纤维化、胸膜粘连明显,病灶吸收极慢,需长期管理。
  • 行胸腔闭式引流者部分可在2周内成功拔管,但仅基于2例成功病例,不能作为通用拔管时限推荐。
  • 原文未提及具体适用与不适用人群的排除标准,不能外推至其他人群。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the clinical characteristics and prognosis of coronavirus disease 2019 (COVID-19) patients complicated with pneumothorax.

METHODS: The clinical data of 7 COVID-19 patients complicated with pneumothorax admitted to Huanggang Central Hospital from January 3 to March 10, 2020 were retrospectively analyzed. The clinical features, diagnosis and treatment were summarized, and experience in the treatment of COVID-19 was shared.

RESULTS: (1) General information: among the 7 patients, 5 were males and 2 were females. Four of them had no underlying disease, and 1 had a history of diabetes and hypertension. One patient had only a history of hypertension. There were 6 cases of right pneumothorax and 1 case of bilateral pneumothorax. The 7 patients had a long hospital stay, all over 4 weeks, mostly complicated with multiple organ dysfunction. (2) Imaging examination: 1 case evolved from the early stage to the advanced stage within 1 week and to the severe stage within 2 weeks. Pneumothorax occurred 4 weeks later, and was absorbed within 2 weeks. The remaining 6 patients presented progressive stage on admission, all of them advanced to severe stage within 1 to 2 weeks, and most of them presented diffused consolidation shadows, striation shadows and fibrosis of both lungs, obvious pleural adhesion, and extremely slow lesion absorption. (3) Treatment: 1 severe patient with pneumothorax 4 weeks after onset was given non-invasive mechanical ventilation. The remaining 6 critically ill patients were treated with endotracheal intubation and mechanical ventilation. Five patients were treated with mechanical ventilation within 3 days after the occurrence of pneumothorax, and 1 patient was treated with mechanical ventilation after 11 days. (4) Outcome: 1 patient without endotracheal intubation was continuously given nasal high-flow oxygen therapy, and the condition was stable. Four of the 6 patients complicated with pneumothorax after endotracheal intubation died, and the other 2 patients successfully removed the drainage tube within 2 weeks of closed thoracic drainage, and their condition gradually stabilized.

CONCLUSIONS: COVID-19 complicated with pneumothorax is a dangerous disease with poor prognosis, and should be paid adequate attention.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Jia L, Wang C, Zhang Y, et al. [Clinical characteristics of coronavirus disease 2019 patients complicated with pneumothorax: analysis of 7 cases]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33198858. doi:10.3760/cma.j.cn121430-20200702-00640

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。